Trusted by:
PRECLINICAL
DEVELOPMENT
CLINICAL DEVELOPMENT
Phase 1 | Phase 2 | Phase 3
LAUNCH /
POST LAUNCH
BRAND MATURITY
Phase 4
Trusted by Top-20 Pharma and 100+ small and medium Biotechs
Rate working with us 9 or 10/10
For leading high-science Pharma and Biotechs
Including two from Science and NSF
PhD & MD qualified scientists and proprietary production pipeline
"Using data from more than 100 studies, Visual Science created the most comprehensive model of HIV virion to date."
"Visual Science spent months combing through the latest research ... and assembling the information into a coherent image."
"Through the use of stunning imagery and attention to detail, Visual Science has captured the dynamic mechanisms of CRISPR-Cas proteins"
Dr. Jennifer Doudna
Nobel Laureate, 2020
"The creativity, scientific competency and professionalism of the Visual Science team not only enabled generation of high quality visuals, but also made it a pleasure to work with them."
Jan Smith | Chief Scientific Officer
Revolution Medicines
"We were impressed by the scientific sophistication of the Visual Science team. Highly competent group with clear understanding of the science. The final video was exceptional."
Michael Zasloff | Chief Science Officer
Enterin
"The animation is both visually remarkable and scientifically accurate – we were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms"
Rosana Kapeller | President, CEO ROME Therapeutics
INCLUDING TWO UNIQUE
Main 3D is the most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic. It's a great match for most MoAs and MoDs for IR needs, alongside HCP communications.
The usual Main 3D animation type in combination with 2D elements. This is an excellent option for MoAs where there's a need to incorporate research data, schematics, or other additional information.
UNIQUE APPROACH
The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.
UNIQUE SCIENTIFIC-GRADE TYPE
Featured:
UNIQUE SCIENTIFIC-GRADE TYPE
Featured:
Awarded:
UNIQUE SCIENTIFIC-GRADE TYPE
A relatively simple, yet still eye-catching 2D animation style is an ideal option for explainer animations, platform or AI-based technologies, alongside cases where IP details must not be disclosed.
Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos
Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos
This type is designed specifically for projects with tight deadlines. Through optimization, we achieve a rapid turnaround without compromising quality or scientific accuracy. The fastest type of 3D animation to produce on the market.
UNIQUE TYPE
A unique combination of scientific-grade molecular simulations that accurately represents real molecular interactions and states, with all the benefits of 2D animation —affordable and fast to produce. Unbeatable quality-to-cost-per-second ratio.
UNIQUE TYPE
Top 20 Pharma undisclosed client, anonymized data
Animation type:
Clinical trial update
Time:
1 week
Client:
Undisclosed
UNIQUE
Type:
Series B deck
Time:
6 weeks
Scope:
IR, scientific flow optimization, design, illustrations, animations
Type:
Corporate deck for public company
Time:
4 weeks
Scope:
Design, illustrations, animations
Type:
Corporate deck for public company
Time:
5 weeks
Scope:
Scientific flow optimization, design, illustrations, animations
Type:
High-end 3D infographics for deck
Time:
1 week
Type:
2D infographics for deck
Time:
1 week
NASDAQ: APGE
Type:
Corporate website for public company
Time:
10 weeks
Scope:
Design, development, illustrations, animations
NASDAQ: ENVB
Type:
Corporate website for public company
Time:
9 weeks
Scope:
Design, development, illustrations, animations
For congress support and in field communications
UNIQUE
UNIQUE
AR brings digital information and virtual
objects into the physical space.
By turning a distinct image on a screen or
physical statue within a space into a marker,
programmed simulated experiences are
triggered for an engaging, self-learning
experience.
Using mobile device, user hovers over
various targets, key steps in surgical procedure
come to life.
Multi-channel use: conference, at-home mobile
A cross-functional strategic exercise
to define the clinical value and scientific
rationale of your molecule
A clear and compelling story
scalable for all external audiences
An internal asset that expedites
approval of external facing assets
Confidential — Not for Public Consumption or Distribution
Medical Affairs
Commercial
Regulatory
Clinical Program
IR & Corporate Comm.
Payer/Market Access/HEOR
The overarching story
of your molecule and
the clinical challenge
it solves
Breaks down the narrative into 5-6 discrete topics,
such as unmet need, MOA, and clinical
trial results
5-8 evidence driven Statements which
support each Concept
Hyperlinked and annotated reference that support each statement
Identifiable Evidence Gaps Needed to Tell
Full Story of your product
Confidential — Not for Public Consumption or Distribution
The VS medical team will review available evidence, and generate
the brief that summarizes
the project plan.
DEFINE THE STRATEGY
VALIDATE & ROLLOUT
VALIDATE & ROLLOUT
ANALYZE THE
LANDSCAPE
Download
Meeting
Mindset
workshop
Draft Core
Concepts
Draft Scientific Statements
Curate Scientific Evidence
Expert
Validation
Functional
Roll-out
Our team and
your internal stakeholders will workshop current audience mindsets, and ID changes
that can ease product uptake.
Informed by the mindset workshop,
VS will draft
an overarching scientific narrative and core concepts to be reviewed by the core team.
With the core concepts settled,
we draft scientific statements to support each
core concepts
and review with
the core team.
The VS team will align & annotate evidence to
agreed scientific statements.
Once evidence is finalized, it is key
to validate with
your audience.
Once finalized,
we recommend reengaging the extended team
to review and adopt.
The core team will align with
Visual Science and drive the effort kickoff to delivery.
The Visual Science team will moderate this process taking
in and adjudicating perspectives.
Extended team includes stakeholders from all internal functions, to take
in perspectives from multiple lenses.
KOLs for veracity, community to test resonance.
Confidential — Not for Public Consumption or Distribution
10 weeks
High-end 3D
High-end 3D
12 weeks
2D
7 weeks
Main 3D
9 weeks
High-end 3D
3D
3D
8 weeks
High-end 3D + Pathway 3D
12 days — yes, days!
8 weeks
High-end 3D
9 weeks
High-end 3D
8 weeks
High-end 3D
High-end 3D
7 weeks
3D
High-end 3D
9 weeks
3D